Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Madrigal Pharmaceuticals, Inc. MDGL NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
54/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$705.67
+34.4%
Metric TTM (2025-03 – 2025-12)
Operating Cash Flow $-189.55M
Capital Expenditure $-467K
Free Cash Flow $-190.02M

People Also View

KRYS
KRYS
Krystal Biotech, Inc.
$270.00
+0.97%
 ACLX
ACLX
Arcellx, Inc.
$114.89
+0.02%
 PTCT
PTCT
PTC Therapeutics, Inc.
$73.01
+3.68%
 TGTX
TGTX
TG Therapeutics, Inc.
$34.56
+2.28%
 TERN
TERN
Terns Pharmaceuticals, Inc.
$52.68
+0.13%
 VKTX
VKTX
Viking Therapeutics, Inc.
$35.52
+1.46%
 SRPT
SRPT
Sarepta Therapeutics, Inc.
$22.15
+1.65%
 DAWN
DAWN
Day One Biopharmaceuticals, Inc.
$21.46
-0.14%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message